Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.
about
The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western CountriesOverview of the Pathogenesis of ANCA-Associated VasculitisNeutrophil Extracellular Traps in ANCA-Associated VasculitisNeutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of MyeloperoxidaseAnti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibodyUpdates in ANCA-associated vasculitisMechanisms of Autoantibody-Induced Pathology.ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal diseaseLinking classification and therapeutic management of vasculitides.Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.Clinical and Immunologic Characteristics of Patients With ANCA-Associated Glomerulonephritis Combined With Membranous Nephropathy: A Retrospective Cohort Study in a Single Chinese CenterMyeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN.Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre.Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polAutoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GNClinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody: A Retrospective Study.Anti-glomerular basement membrane disease: Case series from a tertiary center in North India.Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.B cell-mediated pathogenesis of ANCA-mediated vasculitis.Key advances in the clinical approach to ANCA-associated vasculitis.Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.Review: Neutrophils as Invigorated Targets in Rheumatic DiseasesAnti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.Deglycosylation influences the oxidation activity and antigenicity of myeloperoxidase.Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis.Cathelicidin antimicrobial peptide as a serologic marker and potential pathogenic factor in antineutrophil cytoplasmic antibody-associated vasculitis.Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.
P2860
Q26740451-60BCD41F-3089-4CF6-800E-1365D69F377CQ26740456-08E43B44-2144-4DE5-822F-C5DEE0F695F3Q26742162-DC8E954C-2C20-4DE7-BB95-53F1D8FFA4B2Q26767149-3132347E-BD18-4B80-AEA0-EA591D85DB83Q27023640-BEBB8FB1-8442-4D57-AE50-E90F02AAB274Q28069897-BC5122BE-6C84-4D46-AD56-D51A27D90D2FQ33740580-BDC59F89-00D2-45C4-9EB9-2A81EDE916A6Q35124231-92FF7AC5-C7E6-4A23-96BA-58E52C828B28Q35672892-D57ECCE9-A4BC-4A25-BCE0-825A4C14E483Q35900660-E7822113-9DB0-48BB-B9B1-B4599F6C98E1Q36040078-6EF332CF-A6CC-44F3-80A0-3E6393D565C9Q36256090-AC475EA9-10A7-4B48-9115-01A12EC299ADQ36514958-E07F0EA8-34D8-42C4-A373-DBC19AC234F2Q36770856-75AF0DE6-B436-49EC-96EA-4D1FD8C16DBCQ37328955-003295B4-C091-4464-9E56-62FA9BF1A1FBQ37456456-F38D1404-B099-4DBA-B563-F240A316CA82Q37604720-C6FA5259-10F1-47E1-AFCB-DB4B15D897BFQ37624092-3FDCCAF7-C5CF-414B-9A85-2D774BB71612Q37711277-0AB10663-44B0-4435-A2C7-0082932FB2CFQ38146909-C079BAA3-7050-474B-A07F-8FC6A78BAFC4Q38206946-F154D177-DD4D-4528-9294-4539EE29FF74Q38207938-E49348DE-BFA7-4D5E-ADAC-9D476C66A69EQ38224803-BFB43F98-7987-4A2E-9106-75A5D19535CEQ38227267-13432047-EB51-4501-B1DC-5FE7C9D037E2Q38300451-A3ED6F1C-CEEC-4DBF-A7B2-0293BA25B952Q38512570-7B72C537-453C-4463-A938-6A8A42602C9BQ38601673-9172C61C-5293-4899-81C9-55F7173D0AC4Q38611714-9E8FB80E-B41B-4D7C-AA55-793F3A4B9946Q38821066-5D8E0AAA-ACAB-4204-B8CC-D8ED1A1327A7Q38829722-63C73DEA-8EFC-4136-906C-8C896A5AA441Q39283041-57EC1414-FBC2-480B-8987-A8906D116776Q40041740-C5544F56-C5B7-4F9F-B29D-5BC07DC8FF61Q40054072-57693CC1-5FFB-4065-BE8D-EBB115B6DE37Q40535587-891E35F9-DB24-48BC-9518-21F2C8D31B98Q41394362-58FB695F-7C00-42DB-8851-C79CC093A770Q41892986-FEB3729A-5146-4230-9743-E18FFFC6524DQ42369371-63B53F8A-864C-4900-836E-2A2B5235BDB5Q42385049-9B05E931-7FB5-4CD7-9582-1AA4097FB17EQ42925842-86F79751-3DBE-41A7-B9AC-F092326273E9Q43123391-D0BC680D-954E-42AA-A618-23997129CB58
P2860
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Epitope specificity determines ...... in ANCA-associated vasculitis.
@ast
Epitope specificity determines ...... in ANCA-associated vasculitis.
@en
type
label
Epitope specificity determines ...... in ANCA-associated vasculitis.
@ast
Epitope specificity determines ...... in ANCA-associated vasculitis.
@en
prefLabel
Epitope specificity determines ...... in ANCA-associated vasculitis.
@ast
Epitope specificity determines ...... in ANCA-associated vasculitis.
@en
P2093
P2860
P356
P1476
Epitope specificity determines ...... in ANCA-associated vasculitis.
@en
P2093
A Richard Kitching
Aleeza J Roth
Caroline E Poulton
Coen A Stegeman
Elisabeth A Berg
Gloria A Preston
J Charles Jennette
Jacob J Hess
John Niles
Joshua D Ooi
P2860
P304
P356
10.1172/JCI65292
P407
P577
2013-03-15T00:00:00Z